Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results

Bone Marrow Transplantation volume 33, pages 675–690 (2004)Cite this article

Summary:

Umbilical cord blood (CB) has been rapidly established as an alternative source of stem cells to bone marrow for allogeneic-related and unrelated hematopoietic transplantation. To date, almost 70 000 CB units are available for transplantation and more than 2000 CB transplants (CBT) have been performed, mostly in children, for the treatment of a variety of malignant and nonmalignant conditions. Considerable experience has been rapidly accumulated in this field and many aspects of CBT have been elucidated, while other questions remain unresolved. A concise review of the clinical results achieved after related and unrelated CBT is presented and discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–10122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Knudtzon S . In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974; 43: 357–361.

    CAS  PubMed  Google Scholar 

  3. Nakahata T, Ogawa M . Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 1982; 70: 1324–1328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Emerson SG, Sieff CA, Wang EA et al. Purification of fetal hematopoietic progenitors and demonstration of recombinant. J Clin Invest 1985; 76: 1286–1290.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Christensen RD, Harper TE, Rothstein G . Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr 1986; 109: 1047–1051.

    Article  CAS  PubMed  Google Scholar 

  6. Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828–3832.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gluckman E, Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.

    Article  CAS  PubMed  Google Scholar 

  8. Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89: 4109–4113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cardoso AA, Li ML, Batard P et al. Human umbilical cord blood CD34+ cell purification with high yield of early progenitors. J Hematother 1993; 2: 275–279.

    Article  CAS  PubMed  Google Scholar 

  10. Lu L, Xiao M, Shen RN et al. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993; 81: 41–48.

    CAS  PubMed  Google Scholar 

  11. Han P, Hodge G, Story C et al. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol 1995; 89: 733–740.

    Article  CAS  PubMed  Google Scholar 

  12. Risdon G, Gaddy J, Horie M et al. Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA 1995; 92: 2413–2417.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Barker JN, Krepski TP, DeFor TE et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood vs bone marrow. Biol Blood and Bone Marrow Transplant 2002; 8: 257–260.

    Article  Google Scholar 

  14. Rubinstein P, Rosenfield RE, Adamson JW et al. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993; 81: 1679–1690.

    CAS  PubMed  Google Scholar 

  15. McCullough J, Clay ME, Fautsch S et al. Proposed policies and procedures for the establishment of a cord blood bank. Blood Cells 1994; 20: 609–626.

    CAS  PubMed  Google Scholar 

  16. Donaldson C, Armitage WJ, Denning-Kendall PA et al. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996; 18: 725–731.

    CAS  PubMed  Google Scholar 

  17. Wagner JE, Broxmeyer HE, Cooper S . Umbilical cord and placental blood hematopoietic stem cells: collection, cryopreservation, and storage. J Hematother 1992; 1: 167–173.

    Article  CAS  PubMed  Google Scholar 

  18. Harris DT, Schumacher MJ, Rychlik S et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 1994; 13: 135–143.

    CAS  PubMed  Google Scholar 

  19. Cairo M, Wagner JE . Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 4665–4678.

    CAS  PubMed  Google Scholar 

  20. Reed W, Smith R, Dekovic F et al. Comprehensive banking of sibling donor cord blood for children with malignant and non-malignant disease. Blood 2003; 101: 351–357.

    Article  CAS  PubMed  Google Scholar 

  21. International Forum. Use of umbilical cord blood progenitor cells as an alternative therapy for bone marrow transplantation. Vox Sanguinis 2002; 83: 172–187.

  22. Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214–219.

    Article  CAS  PubMed  Google Scholar 

  23. Wagner JE, Kurtzberg J . Cord blood stem cells. Curr Opin Hematol 1997; 4: 413–418.

    Article  CAS  PubMed  Google Scholar 

  24. Rocha V, Chastang C, Souillet G et al. Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant Group. Bone Marrow Transplant 1998; 21 (Suppl. 3): S59–S62.

    PubMed  Google Scholar 

  25. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373–381.

    Article  CAS  PubMed  Google Scholar 

  26. Gluckman E . Current status of umbilical cord blood hematopoietic stem cells transplantation. Exp Hematol 2000; 28: 1197–1205.

    Article  CAS  PubMed  Google Scholar 

  27. Rocha V, Wagner Jr JE, Sobocinski KA et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846–1854.

    Article  CAS  PubMed  Google Scholar 

  28. Gluckman E, Rocha V, Chastang C . European results of unrelated cord blood transplants. Eurocord Group. Bone Marrow Transplant 1998; 21 (Suppl. 3): S87–S91.

    PubMed  Google Scholar 

  29. Gluckman E, Rocha V, Garnier F et al. Analysis of factors associated with engraftment after umbilical cord blood transplantation. Blood 2001; 96: 588a.

    Google Scholar 

  30. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.

    Article  CAS  PubMed  Google Scholar 

  31. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–166.

    Article  CAS  PubMed  Google Scholar 

  32. Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-vs-host disease. Blood 1996; 88: 795–802.

    CAS  PubMed  Google Scholar 

  33. Thomson BG, Robertson KA, Gowan D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703–2711.

    CAS  PubMed  Google Scholar 

  34. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  35. Barker JN, Davies SM, DeFor T et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.

    Article  CAS  PubMed  Google Scholar 

  36. Locatelli F, Rocha V, Chastang C et al. Cord blood transplantation for children with acute leukemia. Eurocord Transplant Group. Bone Marrow Transplant 1998; 21 (Suppl. 3): S63–S65.

    PubMed  Google Scholar 

  37. Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999; 93: 3662–3671.

    CAS  PubMed  Google Scholar 

  38. Michel G, Rocha V, Arcese W et al. Unrelated cord blood transplantation for childhood AML. Blood 2002; 100 (Suppl. 1): 41a.

    Google Scholar 

  39. Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.

    Article  CAS  PubMed  Google Scholar 

  40. Gluckman E, Rocha V, Chevret S et al. Factors associated with outcome if unrelated cord blood transplant: guidelines for donor choice. An Eurocord study. Blood 2002; 100 (Suppl. 1): 642a.

    Google Scholar 

  41. Rubinstein P, Kurtzberg J, Loberiza F et al. Comparison of unrelated cord blood and unrelated bone marrow transplants for leukemia in children: a collaborative study of the New York Blood Center and the International Bone Marrow Transplant Registry. Blood 1998; 92 (Suppl. 1): 814a.

    Google Scholar 

  42. Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplant in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.

    Article  CAS  PubMed  Google Scholar 

  43. Rocha V, Chastang C, Pasquini R et al. Cord blood transplant in patients with bone marrow failure syndromes. Blood 1998; 92 (Suppl. 1): 136a.

    Google Scholar 

  44. Howrey RP, Martin PL, Ciocci G et al. Unrelated cord blood transplantation for correction of genetic diseases. Blood 1998; 92 (Suppl. 1): 291a.

    Google Scholar 

  45. Niehues T, Rocha V, Filipovich AH et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children: a Eurocord analysis. Br J Haematol 2001; 114: 42–48.

    Article  CAS  PubMed  Google Scholar 

  46. Ortega J, Yaniv L, Rocha V et al. Cord blood transplantation for inborn errors. Blood 1998; 92 (Suppl. 1): 291a.

    Google Scholar 

  47. Ortega JJ, Rocha V, Wall D et al. Unrelated cord blood transplant in children with severe primary immunodeficiencies. An Eurocord analysis. Blood 2001; 98 (Suppl. 1): 667a.

    Google Scholar 

  48. Staba SL, Martin PL, Ciocci GH et al. Correction of Hurler syndrome with unrelated umbilical cord blood transplantation. Blood 2001; 98 (Suppl. 1): 667a.

    Google Scholar 

  49. Gluckman E . Hematopoietic stem cell transplants using umbilical cord blood. N Engl J Med 2001; 344: 1860–1861.

    Article  CAS  PubMed  Google Scholar 

  50. Rocha V, Sanz G, Laporte JP et al. Prognostic factors of outcome after unrelated cord blood transplant in adults with hematologic malignancies. Blood 2000; 96 (Suppl. 1): 587a.

    Google Scholar 

  51. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    Article  CAS  PubMed  Google Scholar 

  52. Iseki T, Ooi J, Tomonari A et al. Unrelated cord blood transplantation in adult patients with hematological malignancy. A single institution experience. Blood 2001; 98 (Suppl. 1): 665a.

    Google Scholar 

  53. Sanz GF, Saavedra S, Planelles D et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 98: 2332–2338.

    Article  CAS  PubMed  Google Scholar 

  54. Long G, Madan B, Kurtzberg J et al. Unrelated umbilical cord blood transplants in adult patients with hematologic malignancies and genetic disorders. Blood 1999; 94 (Suppl. 1): 570a.

    Google Scholar 

  55. Rocha V, Labopin M, Frassoni F et al. Results of unrelated cord blood versus unrelated bone marrow transplant in adults with acute leukemia. A matched pair analysis. Blood 2002; 100 (Suppl. 1): 42a.

    Google Scholar 

  56. Ooi J, Iseki T, Takahashi S et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukemia. Br J Haematol 2002; 118: 140–143.

    Article  PubMed  Google Scholar 

  57. Abu-Ghosh A, Goldman S, Slone V et al. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Bone Marrow Transplant 1999; 24: 535–544.

    Article  CAS  PubMed  Google Scholar 

  58. Moretta A, Maccario R, Fagioli F et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371–379.

    Article  CAS  PubMed  Google Scholar 

  59. Talvensaari K, Clave E, Donay C et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002; 99: 1458–1464.

    Article  CAS  PubMed  Google Scholar 

  60. Stevens CE, Gladstone J, Taylor PE et al. Placental/umbilical cord blood from unrelated donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood 2002; 100: 2662–2664.

    Article  CAS  PubMed  Google Scholar 

  61. Migliaccio AR, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717–2722.

    CAS  PubMed  Google Scholar 

  62. Kogler G, Nurnberger W, Fischer J et al. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high-risk leukemia. Bone Marrow Transplant 1999; 24: 397–403.

    Article  CAS  PubMed  Google Scholar 

  63. Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000; 25: 797–799.

    Article  CAS  PubMed  Google Scholar 

  64. Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1: 1017–1023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood and Bone Marrow Transplant 2002; 8: 368–376.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology/Oncology Department and Bone Marrow Transplantation Unit, Niño Jesus Children's Hospital, Autonomous University, Madrid, Spain

    A I Benito, M A Diaz, M González-Vicent, J Sevilla & L Madero

Authors
  1. A I Benito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M A Diaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M González-Vicent
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Sevilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Madero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L Madero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benito, A., Diaz, M., González-Vicent, M. et al. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 33, 675–690 (2004). https://doi.org/10.1038/sj.bmt.1704405

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704405

Keywords

This article is cited by

Search

Advanced search

Quick links